FGF21 and GDF15 Act Synergistically to Regulate Systemic Metabolic Homeostasis in Mice Lacking OPA1 in Thermogenic Adipocytes
Obesity · 2025-10 · 33 (10) · 1909-1920
DOI: 10.1002/oby.70004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, online erschienen am 02.09.2025. Verfasst von Joshua Peterson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fraternal Order of Eagles Diabetes Research Center and Department of Internal Medicine, Division of Endocrinology and Metabolism, Carver College of M…. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Growth Differentiation Factor 15, Obesity, GTP Phosphohydrolases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association, NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Objective
Our previous studies showed that mice lacking the mitochondrial fusion protein optic atrophy 1 (OPA1 BKO) in brown adipose tissue (BAT) have high metabolic rates and are resistant to diet‐induced obesity (DIO) via effects partially mediated by independent actions of fibroblast growth factor 21 (FGF21) and growth differentiation factor 15 (GDF15) secretion from BAT. We examined whether FGF21 and GDF15 act synergistically, contributing to the systemic metabolic adaptations reported in OPA1 BKO mice.
Methods
We generated mice simultaneously lacking the Opa1 , Fgf21 , and Gdf15 genes in thermogenic adipocytes (TKO) and assessed energy homeostasis and glucose metabolism after regular chow or high‐fat diet feeding.
Results
Young TKO mice fed regular chow had impaired glucose tolerance, while insulin sensitivity was unchanged. Notably, combined Fgf21 and Gdf15 deletion in OPA1 BKO significantly blunted the resistance to DIO and insulin resistance observed in OPA1 BKO mice.
Conclusions
FGF21 and GDF15 act synergistically to maintain glucose homeostasis and promote resistance to DIO in mice lacking OPA1 in BAT, highlighting the potential of combined therapies using FGF21 and GDF15 for the treatment of metabolic disorders. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fraternal Order of Eagles Diabetes Research Center and Department of Internal Medicine, Division of Endocrinology and Metabolism, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
ORCID-Profile: Joshua Peterson, Ayushi Sood
Förderung
- American Heart Association
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Peterson, J., Jena, J., Sood, A., Roitershtein, S., Smith, D., & Pereira, R. O. (2025). FGF21 and GDF15 Act Synergistically to Regulate Systemic Metabolic Homeostasis in Mice Lacking OPA1 in Thermogenic Adipocytes. Obesity, 33(10), 1909-1920. https://doi.org/10.1002/oby.70004
Vancouver
Peterson J, Jena J, Sood A, Roitershtein S, Smith D, Pereira RO. FGF21 and GDF15 Act Synergistically to Regulate Systemic Metabolic Homeostasis in Mice Lacking OPA1 in Thermogenic Adipocytes. Obesity. 2025;33(10):1909-1920. doi:10.1002/oby.70004
BibTeX
@article{Peterson2025,
author = {Peterson, Joshua and Jena, Jayashree and Sood, Ayushi and Roitershtein, Shelly and Smith, David and Pereira, Renata O},
title = {FGF21 and GDF15 Act Synergistically to Regulate Systemic Metabolic Homeostasis in Mice Lacking OPA1 in Thermogenic Adipocytes},
journal = {Obesity},
year = {2025},
volume = {33},
number = {10},
pages = {1909--1920},
doi = {10.1002/oby.70004}
}
EUVIMED